29 | Peptides (Polypeptides)IBA
01/2020
-
08/2008 |
25 | IntegrinsIBA
11/2018
-
05/2007 |
24 | Proteins (Proteins, Gene)FDA Link
10/2020
-
10/2008 |
21 | Pharmaceutical PreparationsIBA
11/2022
-
10/2008 |
13 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
-
01/2011 |
11 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2017
-
09/2009 |
10 | Biomarkers (Surrogate Marker)IBA
04/2022
-
01/2008 |
9 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019
-
01/2009 |
8 | GoldIBA
10/2018
-
06/2013 |
8 | Glucose (Dextrose)FDA LinkGeneric
11/2017
-
09/2005 |
7 | ErbB Receptors (EGF Receptor)IBA
04/2019
-
03/2008 |
7 | AntigensIBA
01/2019
-
10/2011 |
7 | AcidsIBA
01/2019
-
08/2008 |
7 | AlbuminsIBA
01/2019
-
07/2014 |
7 | arginyl-glycyl-aspartic acidIBA
08/2014
-
05/2007 |
6 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2020
-
02/2015 |
6 | LigandsIBA
05/2019
-
01/2011 |
6 | Exenatide (Byetta)FDA Link
01/2019
-
01/2012 |
6 | Messenger RNA (mRNA)IBA
12/2018
-
12/2012 |
6 | Bombesin Receptors (Bombesin Receptor)IBA
01/2018
-
09/2009 |
6 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2018
-
08/2008 |
6 | Matrix Metalloproteinases (MMPs)IBA
11/2014
-
06/2011 |
5 | Biological ProductsIBA
03/2020
-
01/2011 |
5 | Coloring Agents (Dyes)IBA
03/2020
-
03/2011 |
5 | Photosensitizing Agents (Photosensitizers)IBA
01/2020
-
06/2013 |
5 | ProdrugsIBA
03/2019
-
01/2017 |
5 | Contrast MediaIBA
01/2019
-
09/2009 |
5 | Ferritins (Ferritin)IBA
01/2018
-
02/2011 |
5 | Evans Blue (Blue, Evans)FDA Link
01/2018
-
07/2009 |
5 | Radioisotopes (Radionuclides)IBA
01/2018
-
01/2008 |
5 | cyclic arginine-glycine-aspartic acid peptideIBA
09/2012
-
06/2009 |
5 | Integrin alphaVbeta3IBA
02/2010
-
01/2008 |
4 | PolymersIBA
03/2020
-
01/2019 |
4 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
-
01/2017 |
4 | VaccinesIBA
01/2020
-
01/2017 |
4 | NanovaccinesIBA
01/2020
-
03/2016 |
4 | Glucagon-Like Peptide-1 ReceptorIBA
01/2019
-
01/2012 |
4 | Estrogen ReceptorsIBA
12/2018
-
03/2016 |
4 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2018
-
01/2011 |
4 | alfatide IIIBA
12/2018
-
04/2012 |
4 | Gadolinium DTPA (Magnevist)FDA Link
07/2018
-
09/2012 |
4 | Small Interfering RNA (siRNA)IBA
03/2018
-
10/2011 |
4 | cupric sulfide (CuS)IBA
01/2018
-
01/2014 |
4 | BombesinIBA
01/2018
-
09/2009 |
4 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2018
-
06/2012 |
4 | Firefly LuciferasesIBA
01/2017
-
05/2007 |
4 | Cetuximab (Erbitux)FDA Link
01/2017
-
07/2009 |
4 | Chemokine ReceptorsIBA
02/2016
-
01/2012 |
4 | graphene oxideIBA
09/2015
-
10/2012 |
4 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2015
-
10/2011 |
4 | GlucokinaseIBA
01/2014
-
03/2011 |
3 | 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA
01/2020
-
01/2014 |
3 | IonsIBA
10/2019
-
01/2017 |
3 | 177Lu-EB-PSMA-617IBA
06/2019
-
01/2018 |
3 | Glutathione (Reduced Glutathione)IBA
11/2018
-
01/2017 |
3 | DNA (Deoxyribonucleic Acid)IBA
03/2018
-
03/2016 |
3 | Indicators and Reagents (Reagents)IBA
02/2018
-
08/2011 |
3 | Chelating AgentsIBA
01/2018
-
12/2011 |
3 | CopperIBA
01/2018
-
03/2016 |
3 | Oxygen (Dioxygen)IBA
01/2018
-
01/2017 |
3 | Albumin-Bound PaclitaxelFDA Link
12/2017
-
01/2011 |
3 | Monoclonal AntibodiesIBA
11/2017
-
11/2008 |
3 | LuciferasesIBA
10/2017
-
08/2012 |
3 | Sulfhydryl Compounds (Thiols)IBA
10/2015
-
07/2013 |